Univariate analysis | multivariate analysis | ||||
---|---|---|---|---|---|
3 years-BCSS, (%) | P | HR | 95%CI | P | |
Type of cancer | 0.398 | ||||
IBC | 81.4 | 1 | |||
T4-non-IBC | 81.9 | 1.125 | 0.885–1.430 | 0.337 | |
Age,y | 0.532 | ||||
< 50 | 82.8 | 1 | |||
≥ 50 | 81.2 | 1.049 | 0.816–1.347 | 0.711 | |
Race | 0.013 | ||||
Black | 77.3 | 1 | |||
White | 81.9 | 0.906 | 0.684–1.202 | 0.495 | |
Other | 89.0 | 0.583 | 0.353–0.965 | 0.036 | |
Tumor stage | < 0.001 | ||||
IIIB | 84.2 | 1 | |||
IIIC | 70.8 | 2.378 | 1.847–3.061 | < 0.001 | |
Grade | < 0.001 | ||||
1/2 | 90.4 | 1 | |||
3 | 77.3 | 1.84 | 1.355–2.500 | < 0.001 | |
Unknown | 79.6 | 1.919 | 1.077–3.417 | 0.027 | |
Surgery | 0.087 | ||||
Partial mastectomy | 88.7 | 1 | |||
Mastectomy | 81.1 | 1.305 | 0.806–2.112 | 0.279 | |
Tumor subtype | < 0.001 | ||||
HR+/HER2– | 85.2 | 1 | |||
HR+/HER2+ | 92.1 | 0.485 | 0.318–0.740 | 0.001 | |
HR−/HER2+ | 85.2 | 0.867 | 0.588–1.279 | 0.472 | |
HR−/HER2– | 63.6 | 2.164 | 1.652–2.836 | < 0.001 |